title: Late onset tuberculosis infection in patients receiving anti-TNFα therapy.
authors: Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. anne.b.mongey@ucd.ie.
authors: A-B
authors: AB
authors: Mongey
authors: J P
authors: JP
authors: Doran
authors: J
authors: J
authors: Kleinerova
authors: O
authors: O
authors: Fitzgerald
authors: T J
authors: TJ
authors: McDonnell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000276:immunology; D014376:Tuberculosis / Q000139:chemically induced* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab